Patent details

Basic Information

Publication number:

EP3178835

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP161899570

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME

French Title of Invention:

POLYPEPTIDES RECOMBINES ETENDUS ET COMPOSITIONS LES COMPRENANT

German Title of Invention:

VERLÄNGERTE REKOMBINANTE POLYPEPTIDE UND ZUSAMMENSETZUNGEN DAMIT

SPC Number:

Dates

Filing date:

03/02/2010

Grant date:

10/04/2019

EP Publication Date:

14/06/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/04/2019

EP B1 Publication Date:

10/04/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

03/02/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/04/2019

 

 

Name:

Amunix Pharmaceuticals, Inc.

Address:

500 Ellis Street, 94043, Mountain View, CA, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/05/2019

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SPINK, Benjamin

Address:

United States (US)

2

Name:

STEMMER, Willem

Address:

United States (US)

3

Name:

TO, Wayne

Address:

United States (US)

4

Name:

SILVERMAN, Joshua

Address:

United States (US)

5

Name:

SCHELLENBERGER, Volker

Address:

United States (US)

6

Name:

CLELAND, Jeffrey

Address:

United States (US)

7

Name:

WANG, Chia-wei

Address:

United States (US)

8

Name:

GEETHING, Nathan

Address:

United States (US)

Priority

1

Priority Number:

149669 P

Priority Date:

03/02/2009

Priority Country:

United States (US)

2

Priority Number:

185112 P

Priority Date:

08/06/2009

Priority Country:

United States (US)

3

Priority Number:

268193 P

Priority Date:

08/06/2009

Priority Country:

United States (US)

4

Priority Number:

236493 P

Priority Date:

24/08/2009

Priority Country:

United States (US)

5

Priority Number:

236836 P

Priority Date:

25/08/2009

Priority Country:

United States (US)

6

Priority Number:

243707 P

Priority Date:

18/09/2009

Priority Country:

United States (US)

7

Priority Number:

245490 P

Priority Date:

24/09/2009

Priority Country:

United States (US)

8

Priority Number:

280955 P

Priority Date:

10/11/2009

Priority Country:

United States (US)

9

Priority Number:

280956 P

Priority Date:

10/11/2009

Priority Country:

United States (US)

10

Priority Number:

281109 P

Priority Date:

12/11/2009

Priority Country:

United States (US)

Classification

IPC classification:

C07K 1/00; C07K 14/00; C07K 14/47; C07K 14/50; C07K 14/545; C07K 14/58; C07K 14/605; C07K 14/61; C07K 14/745; C07K 17/00; C12N 9/64; C12N 15/62;

Publication

European Patent Bulletin

Issue number:

201915

Publication date:

10/04/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/03/2027

Annual Fee Number:

18

Annual Fee Amount:

262 Euro

Expected Payer:

Last Annual Fee Payment Date:

29/01/2026

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

246 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
15/05/2019	Power Of Attorney	1
28/05/2019	Outgoing Correspondence	1